News & Media

Events
Interim Report, January - June 2021

Read more
Events
ABGSC Life Science Summit

Read more
Events
Annual General Meeting 2021

Read more
Events
Interim Report, January - March 2021

Q1 Conference call, April 28, 2021, at 14.00 (CET). Link to webcast Phone numbers for participants from: Sweden + 46 8...

Read more
Events
Kempen Life Sciences Conference - 2021 Thematic Virtual Series

Read more
Press release
Medivir to participate at the Kempen Life Sciences Conference

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the company will participate at the virtual meeting Kempen Life...

Read more
Press release
Medivir has determined the starting dose for the next part of the phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient has undergone the safety follow-up to identify...

Read more
Press release
Medivir appoints Magnus Christensen as interim CEO

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) announced today that its Board of Directors appoints Magnus Christensen, the company’s CFO,...

Read more
Press release
Medivir 2020 Annual Report published

Stockholm, Sweden - Medivir AB (Nasdaq Stockholm: MVIR) today announces that the Annual Report for 2020 now is available at the...

Read more
Press release
Number of shares and votes in Medivir

Stockholm — Medivir AB (Nasdaq Stockholm: MVIR) today announces that the number of shares and votes in Medivir has changed during...

Read more
Press release
Notice of Annual General Meeting of Medivir AB (publ)

The shareholders of Medivir AB, reg. no. 556238-4361, with its registered office in Huddinge, Stockholm, are hereby summoned to the annual...

Read more
Press release
Last patient with liver cancer included in the monotherapy part of Medivir's phase Ib study with MIV-818

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the last patient with advanced liver cancer has been included...

Read more